Lytix Biopharma AS banner

Wall St Price Targets

6BG Price Forecast
Based on 5 analysts

+47% Upside
from €38.5 today

Lytix Biopharma AS (6BG)’s 12-month stock price forecast through May 2019 has a consensus target of €56.45, implying 47% upside. The forecast is based on price targets from 5 Wall Street analysts.

6BG Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 6BG yet.

Lytix Biopharma AS Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 6BG's stock price target?
Price Target
56.45 EUR

According to Wall Street analysts, the average 1-year price target for 6BG is 56.45 EUR with a low forecast of 55.89 EUR and a high forecast of 58.11 EUR.

Back to Top